67 research outputs found
Recommended from our members
Characterization of the proton beam at the output of the 6.7MeV LEDA RFQ.
The present configuration of the Low-Energy Demonstration Accelerator (LEDA) consists of a 75-keV proton injector, a 6.7-MeV 350-MHz cw radio-frequency quadrupole (RFQ) with associated high-power and lowlevel rf systems, a 52-magnet periodic lattice followed by a short high-energy beam transport (HEBT) and highpower (670-kW cw) beam stop. The rms beam emittance was measured prior to the installation of the 52-magnet lattice, based on wire-scanner measurements of the beam profile at a single location in the HEBT. New measurements with additional diagnostic hardware have been performed to determine the rms transverse beam properties of the beam at the output of the 6.7-MeV LEDA RFQ. The 52-magnet periodic lattice also includes ten beam position monitors (BPMs) evenly spaced in pairs of two. The BPMs provide a measure of the bunched beam current that exhibits nulls at different locations in the lattice. Model predictions of the locations of the nulls and the strength of the bunched beam current are made to determine what information this data can provide regarding the longitudinal beam emittance
Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement.
Beckwith-Wiedemann syndrome (BWS), a human genomic imprinting disorder, is characterized by phenotypic variability that might include overgrowth, macroglossia, abdominal wall defects, neonatal hypoglycaemia, lateralized overgrowth and predisposition to embryonal tumours. Delineation of the molecular defects within the imprinted 11p15.5 region can predict familial recurrence risks and the risk (and type) of embryonal tumour. Despite recent advances in knowledge, there is marked heterogeneity in clinical diagnostic criteria and care. As detailed in this Consensus Statement, an international consensus group agreed upon 72 recommendations for the clinical and molecular diagnosis and management of BWS, including comprehensive protocols for the molecular investigation, care and treatment of patients from the prenatal period to adulthood. The consensus recommendations apply to patients with Beckwith-Wiedemann spectrum (BWSp), covering classical BWS without a molecular diagnosis and BWS-related phenotypes with an 11p15.5 molecular anomaly. Although the consensus group recommends a tumour surveillance programme targeted by molecular subgroups, surveillance might differ according to the local health-care system (for example, in the United States), and the results of targeted and universal surveillance should be evaluated prospectively. International collaboration, including a prospective audit of the results of implementing these consensus recommendations, is required to expand the evidence base for the design of optimum care pathways
How natural disasters can affect environmental concerns, risk aversion, and even politics: evidence from Fukushima and three European countries
ESCAschool study: trial protocol of an adaptive treatment approach for school-age children with ADHD including two randomised trials
Recommended from our members
Reliable-linac design for accelerator-driven subcritical reactor systems.
Accelerator reliability corresponding to a very low frequency of beam interrupts is an important new accelerator requirement for accelerator-driven subcritical reactor systems. In this paper we review typical accelerator-reliability requirements and discuss possible methods for meeting these goals with superconducting proton-linac technology
- …